Related Experiment Video
Updated: May 14, 2026
10:16
Employing Digital Droplet PCR to Detect BRAF V600E Mutations in Formalin-fixed Paraffin-embedded Reference Standard Cell Lines
Published on: October 8, 2015
Summary
Gene patenting and licensing by companies create challenges for patient access to medical tests and impact genetic test development. These practices raise ethical concerns and questions about monopolistic business behaviors and lab-test quality.
Area of Science:
- Biotechnology
- Medical Ethics
- Intellectual Property Law
Background:
- Patenting of genes and genetic tests has become a significant area of legal and commercial activity.
- The control of genetic patents through licensing agreements influences the landscape of diagnostic testing.
Purpose of the Study:
- To examine the implications of gene patenting and licensing on patient access to medical genetic tests.
- To analyze the ethical considerations and potential for monopolistic practices arising from genetic patent control.
- To assess the impact on the quality of laboratory testing and the future trajectory of genetic test innovation.
Main Methods:
- Review of existing literature on gene patenting and licensing.
- Analysis of legal frameworks governing intellectual property in genetics.
- Case study examination of specific genetic tests and their patent/licensing structures.
Main Results:
- Patents on genes and their associated tests can restrict availability and increase costs for patients.
- Licensing strategies may lead to monopolistic control, limiting competition and potentially compromising test quality.
- Ethical debates persist regarding the ownership of human genetic information and its commercialization.
Conclusions:
- The current system of gene patenting and licensing presents multifaceted challenges to equitable patient access, ethical standards, and innovation in genetic diagnostics.
- Policy and legal reforms may be necessary to balance intellectual property rights with patient welfare and scientific advancement.
